fundvisualizer.com

State Street International Stock Sel NSSAIX

Performance (before sales charge)

As of 03/31/2024

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 02/29/2024
Stock
2.46%
Non-U.S. Stock
95.74%
Bond
0.00%
Non-U.S. Bond
0.00%
Preferred
0.00%
Convertible
0.00%
Cash
1.05%
Other
0.75%

Due to rounding, percentages may not equal 100%.

Sectors

As of 02/29/2024

Basic materials

8.59%

Consumer cyclical

11.27%

Financial services

17.08%

Real estate

3.67%

Consumer defensive

7.28%

Health care

11.51%

Utilities

4.12%

Communication services

2.91%

Energy

2.31%

Industrials

17.93%

Technology

10.15%

Top 10 holdings

As of 02/29/2024

Novartis AG Registered Shares
2.12%
Sanofi SA
1.52%
GSK PLC
1.45%
Mitsubishi Corp
1.38%
Msci Eafe Mar24 Ifus 20240315
1.38%
CRH PLC
1.37%
Munchener Ruckversicherungs-Gesellschaft AG
1.36%
Deutsche Telekom AG
1.36%
Mitsui & Co Ltd
1.34%
Novo Nordisk A/S Class B
1.33%
Fund assets

$134.89 Million

Share class

Inst

Morningstar category

Foreign Large Value

Expense ratio

1.00%

Investment objective

Foreign Stock

Documents